Silver Book Fact

The excess economic burden of visual impairment and blindess of individuals age 40 and older on the individual, caregivers, and other health care payers is an estimated $5.48 billion annually– $5.12 billion in additional medical care expenditures and $360 million in informal care costs.

Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The number of Americans age 40 and older with diabetic retinopathy is projected to triple between 2005 and 2050–increasing from 5.5 million to 16 million.  The number of people age…  
  • Annual Total Burden to the U.S. Economy of AMD, Cararact, Diabetic Retinopathy, Glaucoma, Refractive Errors, Visual Impairment and Blindness  
  • Global DR Prevalence
    DR affects more than 126 million people around the world— 37 million with vision-threatening DR.  
  • For beneficiaries with wet age-related macular degeneration (AMD), annual Medicare part B payments for vision care increased from $1,504 per beneficiary in 1994 to $3,263 in 2006–due in large part…  
  • Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in people over the age of 65.